Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of [Azilect] Rasagiline in Levodopa-treated Parkinson's Patients With Motor Fluctuations in Korea
Phase of Trial: Phase III
Latest Information Update: 02 Dec 2013
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 29 Jun 2012 Actual patient number is 132 as reported by ClinicalTrials.gov.
- 29 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Apr 2012 Planned number of patients changed from 150 to 130 as reported by ClinicalTrials.gov.